Literature DB >> 24768125

Automated high-throughput protein purification using an ÄKTApurifier and a CETAC autosampler.

Daniel Yoo1, Justin Provchy1, Cynthia Park1, Craig Schulz1, Kenneth Walker2.   

Abstract

As the pace of drug discovery accelerates there is an increased focus on screening larger numbers of protein therapeutic candidates to identify those that are functionally superior and to assess manufacturability earlier in the process. Although there have been advances toward high throughput (HT) cloning and expression, protein purification is still an area where improvements can be made to conventional techniques. Current methodologies for purification often involve a tradeoff between HT automation or capacity and quality. We present an ÄKTA combined with an autosampler, the ÄKTA-AS, which has the capability of purifying up to 240 samples in two chromatographic dimensions without the need for user intervention. The ÄKTA-AS has been shown to be reliable with sample volumes between 0.5 mL and 100 mL, and the innovative use of a uniquely configured loading valve ensures reliability by efficiently removing air from the system as well as preventing sample cross contamination. Incorporation of a sample pump flush minimizes sample loss and enables recoveries ranging from the low tens of micrograms to milligram quantities of protein. In addition, when used in an affinity capture-buffer exchange format the final samples are formulated in a buffer compatible with most assays without requirement of additional downstream processing. The system is designed to capture samples in 96-well microplate format allowing for seamless integration of downstream HT analytic processes such as microfluidic or HPLC analysis. Most notably, there is minimal operator intervention to operate this system, thereby increasing efficiency, sample consistency and reducing the risk of human error.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Automated chromatography; High throughput purification; Multi-dimensional chromatography; ÄKTA

Mesh:

Substances:

Year:  2014        PMID: 24768125     DOI: 10.1016/j.chroma.2014.04.014

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Application of the Protein Maker as a platform purification system for therapeutic antibody research and development.

Authors:  Geneviève Hélie; Marie Parat; Frédéric Massé; Cory J Gerdts; Thomas P Loisel; Allan Matte
Journal:  Comput Struct Biotechnol J       Date:  2016-06-16       Impact factor: 7.271

2.  A Streamlined, Automated Protocol for the Production of Milligram Quantities of Untagged Recombinant Rat Lactate Dehydrogenase A Using ÄKTAxpressTM.

Authors:  Matthew W Nowicki; Elizabeth A Blackburn; Iain W McNae; Martin A Wear
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

3.  The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells.

Authors:  Lei Bi; Xiaojing Yan; Ye Yang; Lei Qian; Yuan Tian; Jian-Hua Mao; Weiping Chen
Journal:  Oncotarget       Date:  2017-09-28

4.  Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.

Authors:  Thomas Van Blarcom; Kevin Lindquist; Zea Melton; Wai Ling Cheung; Chris Wagstrom; Dan McDonough; Cendy Valle Oseguera; Sheng Ding; Andrea Rossi; Shobha Potluri; Purnima Sundar; Steven Pitts; Marina Sirota; Meri Galindo Casas; Yu Yan; Jeffrey Jones; Zygy Roe-Zurz; Surabhi Srivatsa Srinivasan; Wenwu Zhai; Jaume Pons; Arvind Rajpal; Javier Chaparro-Riggers
Journal:  MAbs       Date:  2017-12-14       Impact factor: 5.857

Review 5.  Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring.

Authors:  Marsela Jorgolli; Tanner Nevill; Aaron Winters; Irwin Chen; Su Chong; Fen-Fen Lin; Marissa Mock; Ching Chen; Kim Le; Christopher Tan; Philip Jess; Han Xu; Agi Hamburger; Jennitte Stevens; Trent Munro; Ming Wu; Philip Tagari; Les P Miranda
Journal:  Biotechnol Bioeng       Date:  2019-06-24       Impact factor: 4.530

6.  Rational selection of building blocks for the assembly of bispecific antibodies.

Authors:  Danyang Gong; Timothy P Riley; Krzysztof P Bzymek; Ana R Correia; Danqing Li; Christopher Spahr; John H Robinson; Ryan B Case; Zhulun Wang; Fernando Garces
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

7.  Development of a robust and semi-automated two-step antibody purification process.

Authors:  Xiaomin Yang; Richard Yuan; Christopher Garcia; Jessica Berry; Denisa Foster; Dongmei He; Gui-Feng Zhang; Bryan E Jones
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.